MADRIGAL PHARMACEUTICALS, INC. Compensation Agreements
7 Contracts & Agreements
- Supplemental Compensation Recovery Policy (Filed With SEC on May 7, 2024)
- Non-Employee Director Equity Compensation Policy (Filed With SEC on May 6, 2021)
- SYNTA PHARMACEUTICALS CORP. AMENDED AND RESTATED* DIRECTOR COMPENSATION POLICY (Filed With SEC on August 6, 2015)
- SYNTA PHARMACEUTICALS CORP. AMENDED AND RESTATED* DIRECTOR COMPENSATION POLICY (Filed With SEC on May 8, 2014)
- SYNTA PHARMACEUTICALS CORP. AMENDED AND RESTATED* DIRECTOR COMPENSATION POLICY (Filed With SEC on May 3, 2012)
- SYNTA PHARMACEUTICALS CORP. AMENDED AND RESTATED* DIRECTOR COMPENSATION POLICY (Filed With SEC on August 4, 2009)
- SYNTA PHARMACEUTICALS CORP. AMENDED AND RESTATED* DIRECTOR COMPENSATION POLICY (Filed With SEC on August 7, 2008)